Emmanouilides C. Target long-term responders in indolent non-Hodgkin’s lymphoma: 90Y-ibritumomabtiuxetan. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2024 Nov. 22];2(7). Available from: https://www.pagepress.org/journals/hmr/article/view/396